Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 46 | 67 | 63 | 73 | 76 |
| Gross Profit | 46 | 67 | 63 | 73 | 76 |
| Operating Expenses | 668 | 750 | 317 | 1,092 | 1,323 |
| Operating Income | -622 | -683 | -254 | -1,019 | -1,247 |
| Interest Expense | 119 | 105 | 34 | 76 | 14 |
| Other Income | -2,600 | 0 | 296 | 0 | 0 |
| Pre-tax Income | -3,341 | -788 | 8 | -1,095 | -1,261 |
| Net Income Continuous | -3,341 | -788 | 3,850 | -1,095 | -1,261 |
| Net Income | $-3,341 | $-788 | $3,850 | $-1,095 | $-1,261 |
| EPS Basic Total Ops | -0.15 | -0.04 | 0.00 | -0.05 | -0.06 |
| EPS Basic Continuous Ops | -0.15 | -0.04 | 0.18 | -0.05 | -0.06 |
| EPS Diluted Total Ops | -0.15 | -0.04 | 0.00 | -0.05 | -0.06 |
| EPS Diluted Continuous Ops | -0.15 | -0.04 | 0.18 | -0.05 | -0.06 |
| EBITDA(a) | $-519 | $-583 | $-157 | $-924 | $-1,161 |